X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
travoprost (15) 15
glaucoma (14) 14
humans (14) 14
index medicus (13) 13
drug combinations (12) 12
open-angle glaucoma (12) 12
cloprostenol - analogs & derivatives (11) 11
ocular hypertension (11) 11
ophthalmology (11) 11
female (10) 10
intraocular pressure - drug effects (10) 10
male (10) 10
middle aged (10) 10
glaucoma, open-angle - drug therapy (9) 9
medicine & public health (9) 9
travoprost/timolol (9) 9
aged (8) 8
intraocular pressure (8) 8
pharmacology & pharmacy (8) 8
prospective studies (8) 8
timolol - adverse effects (8) 8
timolol - therapeutic use (8) 8
travoprost/timolol fixed combination (8) 8
antihypertensive agents - adverse effects (7) 7
cloprostenol - therapeutic use (7) 7
internal medicine (7) 7
pharmacology/toxicology (7) 7
timolol - administration & dosage (7) 7
antihypertensive agents - administration & dosage (6) 6
antihypertensive agents - therapeutic use (6) 6
cloprostenol - adverse effects (6) 6
glaucoma, open-angle - physiopathology (6) 6
latanoprost (6) 6
treatment outcome (6) 6
benzalkonium chloride (5) 5
bimatoprost (5) 5
cloprostenol - administration & dosage (5) 5
efficacy (5) 5
glaucoma - drug therapy (5) 5
intraocular-pressure (5) 5
ocular hypertension - drug therapy (5) 5
pharmacotherapy (5) 5
research and development (5) 5
therapy (5) 5
timolol maleate (5) 5
tonometry, ocular (5) 5
adherence (4) 4
adult (4) 4
cross-over studies (4) 4
eye diseases (4) 4
genetic structures (4) 4
geriatrics/gerontology (4) 4
hypertension (4) 4
latanoprost/timolol (4) 4
original research (4) 4
patients (4) 4
safety (4) 4
sense organs (4) 4
timolol (4) 4
timolol fixed combination (4) 4
0.5-percent ophthalmic solution (3) 3
adis drug profiles (3) 3
aged, 80 and over (3) 3
dorzolamide (3) 3
double-blind method (3) 3
exfoliation syndrome - drug therapy (3) 3
exfoliative glaucoma (3) 3
fixed combinations (3) 3
ocular hypertension - physiopathology (3) 3
ophthalmic solutions - administration & dosage (3) 3
primary open-angle glaucoma (3) 3
prostaglandin analogs (3) 3
prostaglandins f, synthetic - adverse effects (3) 3
prostaglandins f, synthetic - therapeutic use (3) 3
0.004-percent/timolol 0.5-percent (2) 2
adrenergic beta-antagonists - administration & dosage (2) 2
analysis (2) 2
animals (2) 2
bimatoprost/timolol (2) 2
cardiology (2) 2
clinical ophthalmology (2) 2
cloprostenol - pharmacology (2) 2
dosage and administration (2) 2
drug administration schedule (2) 2
drug substitution (2) 2
drug therapy, combination (2) 2
dry eye (2) 2
endocrinology (2) 2
exfoliation syndrome - physiopathology (2) 2
geriatrics & gerontology (2) 2
health technology assessment (2) 2
in-vitro (2) 2
intraocular-pressure control (2) 2
latanoprost 0.005-percent (2) 2
medication (2) 2
medicine, research & experimental (2) 2
oncology (2) 2
ophthalmic drugs (2) 2
ophthalmic solutions (2) 2
ophthalmic solutions - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Ophthalmology, ISSN 0007-1161, 07/2013, Volume 97, Issue 7, pp. 857 - 861
Journal Article
Journal of Glaucoma, ISSN 1057-0829, 01/2012, Volume 21, Issue 1, pp. 55 - 59
Journal Article
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 02/2009, Volume 87, Issue 1, pp. 71 - 76
Journal Article
Advances in Therapy, ISSN 0741-238X, 6/2014, Volume 31, Issue 6, pp. 592 - 603
To compare the 24-h intraocular pressure (IOP) control and tolerability of travoprost/timolol benzalkonium chloride (BAK)-free (TTFC) vs. latanoprost/timolol... 
Latanoprost/timolol | OSD | Rheumatology | Polyquad | Internal Medicine | Oncology | 24-h intraocular pressure (IOP) control | Benzalkonium chloride | Fixed combinations | Ocular surface | Travoprost/timolol | Medicine & Public Health | Ophthalmology | Cardiology | Pharmacology/Toxicology | Endocrinology | MEDICINE, RESEARCH & EXPERIMENTAL | POLYQUATERNIUM-1 | RISK-FACTORS | EYE WORKSHOP 2007 | OPEN-ANGLE GLAUCOMA | INTRAOCULAR-PRESSURE CONTROL | DRY EYE | PRESERVED TRAVOPROST | PHARMACOLOGY & PHARMACY | PROSTAGLANDIN ANALOGS | Travoprost - adverse effects | Intraocular Pressure - drug effects | Prospective Studies | Tonometry, Ocular - methods | Humans | Middle Aged | Glaucoma, Open-Angle - diagnosis | Antihypertensive Agents - administration & dosage | Timolol - administration & dosage | Male | Treatment Outcome | Drug Monitoring - methods | Prostaglandins F, Synthetic - adverse effects | Antihypertensive Agents - adverse effects | Glaucoma, Open-Angle - drug therapy | Cross-Over Studies | Drug Synergism | Prostaglandins F, Synthetic - administration & dosage | Female | Neuroprotective Agents - adverse effects | Neuroprotective Agents - administration & dosage | Drug Combinations | Travoprost - administration & dosage | Timolol - adverse effects | Glaucoma | Surface active agents | Analysis | Health technology assessment
Journal Article
Journal Article
Journal Article
Clinical Ophthalmology, ISSN 1177-5467, 2011, Volume 5, Issue 1, pp. 187 - 191
Journal Article
2007, Volume 24, Issue 12, 10
Glaucoma is a leading cause of irreversible visual loss. This potentially blinding disease is a progressive optic neuropathy associated with elevated... 
Latanoprost/timolol | Glaucoma | Epinephrine | Betaxolol | Dorzolamide/timolol | Timolol/pilocarpine | Dorzolamide | Brimonidine | Pilocarpine | Travoprost/timolol | Research and development | Bimatoprost/timolol | Latanoprost | Brimonidine/timolol | Timolol | Bimatoprost | Travoprost | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Geriatrics/Gerontology | Dorzolamide, therapeutic use | Dorzolamide/timolol, therapeutic use | Bimatoprost/timolol, therapeutic use | Bimatoprost, therapeutic use | Brimonidine, therapeutic use | Betaxolol, therapeutic use | Brimonidine/timolol, therapeutic use | UNITED-STATES | OPHTHALMIC SOLUTION | ANTIGLAUCOMA MEDICATION | OPEN-ANGLE GLAUCOMA | EFFICACY | OCULAR HYPERTENSION | RANDOMIZED-TRIAL | INDIVIDUAL COMPONENTS | PHARMACOLOGY & PHARMACY | INTRAOCULAR-PRESSURE | DORZOLAMIDE-TIMOLOL COMBINATION | GERIATRICS & GERONTOLOGY | Intraocular Pressure - drug effects | Humans | Antihypertensive Agents - administration & dosage | Timolol - administration & dosage | Adrenergic alpha-Agonists - therapeutic use | Adrenergic alpha-Agonists - administration & dosage | Adrenergic alpha-Agonists - adverse effects | Ophthalmic Solutions | Adrenergic beta-Antagonists - adverse effects | Carbonic Anhydrase Inhibitors - adverse effects | Timolol - therapeutic use | Adrenergic beta-Antagonists - administration & dosage | Adrenergic beta-Antagonists - therapeutic use | Carbonic Anhydrase Inhibitors - therapeutic use | Timolol - adverse effects | Prostaglandins - therapeutic use | Prostaglandins - adverse effects | Carbonic Anhydrase Inhibitors - administration & dosage | Glaucoma - drug therapy | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Patient Compliance | Prostaglandins - administration & dosage | Administration, Topical | Drug Combinations | Geriatrics | Index Medicus
Book Review